[ORGANIZATION]
SION-719
Featured in 1 tracked story · first seen
Situations
Sionna Therapeutics cystic fibrosis drug trial failure
2 clusters · 4 sources · last updated
Latest: Vertex Pharmaceuticals maintains cystic fibrosis market lead after Sionna Therapeutics trial failure
Sionna Therapeutics discontinued its experimental cystic fibrosis drug, SION-719, after a mid-stage clinical trial failed to show meaningful benefits. The trial, which tested the drug as an adjunctive treatment alongside